A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Nicardipine (CARDENE IV)

Nicardipine relaxes blood vessels to lower blood pressure and treat angina.

First FDA approval1992-01-30
Generic availableYes · 18 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$3.5M in CY2024 Part D spend6K claims · 2K beneficiaries · 329 plans surveyed

Lowest NADAC
$1.37/unit
12 NDCs benchmarked, lowest of all strengths.
Average NADAC
$2.66
Across all dosage forms in distribution.
Highest NADAC
$3.94
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Nicardipine used for?

Nicardipine relaxes blood vessels to lower blood pressure and treat angina.

Is there a generic for Nicardipine?

Yes. 28 ANDAs filed at FDA, 18 generic manufacturers currently shipping.

How much does my plan pay for Nicardipine?

Across 329 Part D plans, Nicardipine averages $2.66/unit (NADAC). Lowest available: $1.37/unit. Highest in distribution: $3.94/unit.

Is Nicardipine on the FDA shortage list?

No. Nicardipine is not currently on the FDA Drug Shortage Database.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Dihydropyridine Calcium Channel Blocker6 alternatives in D1
01
Amlodipine
Brand: Katerzia
$0.011Lowest NADAC
19Generic mfrs
$515.5MCY24 Part D spend
Compare →
02
Amlodipine and Atorvastatin
Brand: Caduet
$1.01Lowest NADAC
5Generic mfrs
CY24 Part D spend
Compare →
03
Amlodipine and Benazepril
Brand: Lotrel
$0.094Lowest NADAC
5Generic mfrs
CY24 Part D spend
Compare →
04
Amlodipine and Olmesartan Medoxomil
Brand: Azor
$0.240Lowest NADAC
9Generic mfrs
CY24 Part D spend
Compare →
05
Clevidipine
Brand: Cleviprex
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Clevipidine
Brand: Cleviprex
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (12 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.